‘Patient information’: a case study in EU bureacracy
February 21, 2012
Three years after it was proposed the EU Information to Patients Directive is in limbo European health ministers have poured cold water on a long-standing EU proposal to allow pharmaceutical companies to provide information on medicines directly to patients. Ministers say the Information to Patients Directive could increase red tape for government agencies and companies… » read more
Posted by Gary Finnegan